Arcadia Biosciences Cash Flow - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.97 $0.07 (6.73%) RKDA stock closing price Feb 17, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Arcadia Biosciences needs to disclose. Financials statements like the income statement and balance sheet show that the company has Arcadia Biosciences profits and Arcadia Biosciences debt, while the cash flow statement provides details of cash flow movments. Arcadia Biosciences stock analysis shows negative net income cash flow of $-13.91M for 2016-Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   RKDA decrease in investments stood at a negative value of $-1.1M for the latest 2016-Q3. View details of Arcadia Biosciences cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Arcadia Biosciences Net Income Cash Flow
-13.91M-9.74M-5.19M-17.95M-14.09M-9.48M-5.8M-18.33M-16.35M-9.28M
Depreciation Depletion Amortization Cash-Flow0.34M0.28M0.14M0.37M0.21M0.14M0.07M0.35M0.27M0.18M
Net Increase (Decrease) in Assets Liabilities-0.01M0.11M-0.07M-0.05M0.52M0.81M1.2M-1.33M-0.08M-0.85M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.8M0.49M0.26M2.52M2.2M1.93M1.92M4.53M4.03M1.53M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-12.77M-8.84M-4.85M-15.1M-11.16M-6.58M-2.59M-14.78M-12.12M-8.42M
Increase (Decrease) in Prop Plant And Equipment-0.22M-0.19M-0.13M-0.14M-0.08M-0.02M-0.01M-0.14M-0.03M-
Acquisition Disposition of Subsidiaires--------1.45M-1.45M-0.95M
Increase (Decrease) in Investments-0.88M12.2M10.46M-46.21M-11.29M-----
Other Cash Inflow (Outflow) from Investment Activities----------
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-1.1M12M10.32M-46.36M-11.37M-0.02M-0.01M-1.59M-1.48M-0.94M
Issuance (Purchase) of Equity Shares0.42M0.27M0.13M68.58M68.39M68.25M-32.86M32.85M32.84M
Issuance (Repayment) of Debt Securities---10.2M8.87M8.87M-1.45M-1.15M-0.89M-0.63M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.04M-0.04M-0.04M-9.92M-8.34M-7.09M-1.23M-1.59M-0.01M-
Arcadia Biosciences Net Cash from (used by) Financing Activities
0.38M0.22M0.09M68.87M68.92M70.03M-2.68M30.11M31.94M32.21M
Effect of Exchange Rate Changes on Cash----------
Arcadia Biosciences Net Change in Cash & Cash Equivalents
-13.5M3.38M5.56M7.4M46.39M63.43M-5.29M13.73M18.33M22.84M
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M-------
Cash & Equivalents at Year End10.47M27.36M29.54M23.97M62.96M80M11.27M16.57M21.17M25.67M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

While Arcadia Biosciences stock price history provides the price history of a stock, Arcadia Biosciences stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Arcadia Biosciences had a Net Change in Cash and Cash Equivalents of $-13.5M for the latest quarter 2016-Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Arcadia Biosciences stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Arcadia Biosciences reported a negative operating cash flow of $-12.77M for 2016-Q3 and has seen a decrease from the previous quarter. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $-12.77M for RKDA in last quarter report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $0.38M for Arcadia Biosciences.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-3.67